IREN Limited carries a market capitalization of 16.66B, placing it among publicly traded companies globally. Its enterprise value stands at 27.08B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 16.66B |
| Enterprise Value | 27.08B |
IREN Limited currently has 380.19M shares outstanding.
| Shares Outstanding | 380.19M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
IREN Limited trades at a trailing price-to-earnings ratio of 186.71. The price-to-sales ratio is 28.13, and the price-to-book ratio stands at 6.00.
| PE Ratio | 186.71 |
| PS Ratio | 28.13 |
| PB Ratio | 6.00 |
| P/TBV Ratio | 6.56 |
| P/FCF Ratio | 3.40 |
| P/OCF Ratio | 9.47 |
On an enterprise value basis, IREN Limited trades at an EV/EBITDA multiple of 694.69 and an EV/FCF ratio of 4.16. The EV/Sales ratio of 38.30 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 5,623.14 provides insight into valuation relative to core operating earnings.
| EV / Sales | 38.30 |
| EV / EBITDA | 694.69 |
| EV / EBIT | 5,623.14 |
| EV / FCF | 4.16 |
IREN Limited maintains a current ratio of 3.55, meaning it holds 3.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 187.30, indicating elevated leverage, while an interest coverage ratio of 0.66 demonstrates limited ability to service its debt obligations.
| Current Ratio | 3.55 |
| Quick Ratio | 2.68 |
| Debt / Equity | 187.30 |
| Debt / EBITDA | 201.13 |
| Interest Coverage | 0.66 |
| Return on Equity (ROE) | -23.41 |
| Return on Assets (ROA) | -7.50 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 18.21 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Over the trailing twelve months, IREN Limited has paid -6.06M in income taxes, reflecting an effective tax rate of 33.15.
| Income Tax | -6.06M |
| Effective Tax Rate | 33.15 |
IREN Limited's stock has gained approximately 11.40811% over the past 52 weeks. The 50-day moving average sits at 40.38, while the 200-day moving average is 45.54.
| Beta (5Y) | N/A |
| 52-Week Price Change | 11.40811% |
| 50-Day Moving Average | 40.38 |
| 200-Day Moving Average | 45.54 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, IREN Limited generated 707.01M in revenue and converted that into -702.62M in net income, yielding earnings per share of -2.12. EBITDA reached 38.98M, while operating income came in at -378.75M.
| Revenue | 707.01M |
| Gross Profit | 440.64M |
| Operating Income | -378.75M |
| Pretax Income | -708.68M |
| Net Income | -702.62M |
| EBITDA | 38.98M |
| EBIT | -378.75M |
| Earnings Per Share (EPS) | -2.12 |
IREN Limited holds 5.90B in cash and equivalents against 7.84B in total debt, resulting in a net debt position of 1.70B. Total book value stands at 4.19B, with working capital of 5.67B providing operational flexibility.
| Cash & Cash Equivalents | 5.90B |
| Total Debt | 7.84B |
| Net Debt | 1.70B |
| Equity (Book Value) | 4.19B |
| Book Value Per Share | 11.01 |
| Working Capital | 5.67B |
IREN Limited produced 2.10B in operating cash flow over the past twelve months. After subtracting -4.34B in capital expenditures, free cash flow totaled -2.24B - equivalent to -7.46 per share.
| Operating Cash Flow | 2.10B |
| Capital Expenditures | -4.34B |
| Free Cash Flow | -2.24B |
| FCF Per Share | -7.46 |
IREN Limited operates with a gross margin of 62.32, reflecting its pricing power and cost economics. The operating margin of -53.57 and net profit margin of -99.38 provide insight into operational efficiency.
| Gross Margin | 62.32 |
| Operating Margin | -53.57 |
| Pretax Margin | -100.24 |
| Profit Margin | -99.38 |
| EBITDA Margin | 5.51 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -38.51 |
| FCF Yield | 29.43 |
IREN Limited posts an Altman Z-Score of 1.59, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.59 |